2James J, Evans, Sin--Soo Jeun, et al. Molecular alterations in the neurofibromatsis type 2 gene and its protein rarely occurring in meningothelial meningiomas [J].J Neurosurg, 9000,94:111.
3Pieper DR, Al-Mefty O, Hanada Y, et al. Hyperostosis associated with meningioma of the cranial base: secondary changes or tumor invasion [J]. Neurosurgery, 1999.44 ( 4 ) :742.
4Weber RG, Bostrom J, Wolter M, et al. Analysis of genomic alteration benign,atypical and an aplastic meningiomas:toward ageneti model of meningioma aprogression[J]. Proc Natl Acad Sci U. S.A,1997,94(26) : 14719.
5Schwechheimer K, Zhou L, Birchmeier W, et al. E--cadheerin in human brain tumors: loss of immunoreactivity in malignant meningiomas[J]. Virch Arch,1998,432(2) : 163.
6Hilbig A,Barbosa--Coutinho LM. Meningiomas an hormonal receptors. Immunohistoehemical study in typical and nontypical tumors[J]. Arq Neuropsiquiatr,1998,56(2):193.
7Hsu DW, Efird JT, Hedley--Whyte ET, et al. Progesterone and estrogen receptors in meningiomas: prognostic considerations[J]. J Neurosurg,1997,86(1) : 113.
8S. Coulibaly, H. Schwihla, M. Abrahamson. A. et al.Glossl and L. Mach: Modulation of invasive properties of murine squamous carcinoma cells by heterologous expression of cathepsin B and cystatin C[J]. International Journal Cancer.1999,83 : 526.
9Khan A, Krishna M,Baker SP, et al. Cathepsln Bexpresslon aud its correlation with tumor--associated laminin and tumor progression in gastric cancer[J]. Arch Pathol Lab Med, 1998,122:172.
10Herszenyi L, Plebani M, Carraro P ,et al. Proteases in gastrointestinal neoplastic diseases[J]. Clin Chim Acta, 2000,291 : 171.
